4//SEC Filing
Global Blood Therapeutics, Inc. 4
Accession 0000899243-15-003023
CIK 0001629137operating
Filed
Aug 12, 8:00 PM ET
Accepted
Aug 13, 12:21 PM ET
Size
8.1 KB
Accession
0000899243-15-003023
Insider Transaction Report
Form 4
Brown Willie L. Jr.
Director
Transactions
- Award
Stock Option (right to buy)
2015-08-11+15,000→ 15,000 totalExercise: $20.00Exp: 2025-08-10→ Common Stock (15,000 underlying) - Award
Stock Option (right to buy)
2015-08-11+8,600→ 8,600 totalExercise: $20.00Exp: 2025-08-10→ Common Stock (8,600 underlying)
Footnotes (3)
- [F1]The shares subject to this option shall vest and become exercisable in 12 equal monthly installments with the first installment on September 11, 2015, such that this option is fully exercisable on August 11, 2016. This option is subject to accelerated vesting upon a change of control of the Issuer.
- [F2]Not applicable.
- [F3]The shares subject to this option shall vest and become exercisable in 36 equal monthly installments with the first installment on August 23, 2015, such that this option is fully exercisable on July 23, 2018. This option is subject to accelerated vesting upon a change of control of the Issuer.
Documents
Issuer
Global Blood Therapeutics, Inc.
CIK 0001629137
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001629137
Filing Metadata
- Form type
- 4
- Filed
- Aug 12, 8:00 PM ET
- Accepted
- Aug 13, 12:21 PM ET
- Size
- 8.1 KB